Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (56) GO Terms (4) Nucleotides (160) Proteins (73) Interactants (44) Wiki
XB-GENEPAGE-1010482

Papers associated with gria3



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1 2 ???pagination.result.next???

Sort Newest To Oldest Sort Oldest To Newest

Kaitocephalin antagonism of glutamate receptors expressed in Xenopus oocytes., Limon A, Reyes-Ruiz JM, Vaswani RG, Chamberlin AR, Miledi R., ACS Chem Neurosci. March 17, 2010; 1 (3): 175-181.


DCP-LA stimulates AMPA receptor exocytosis through CaMKII activation due to PP-1 inhibition., Kanno T, Yaguchi T, Nagata T, Tanaka A, Nishizaki T., J Cell Physiol. October 1, 2009; 221 (1): 183-8.


Reconstitution of depolarization and Ca2+-evoked secretion in Xenopus oocytes monitored by membrane capacitance., Cohen R, Schmitt BM, Atlas D., Methods Mol Biol. January 1, 2008; 440 269-82.


Properties of GluR3 receptors tagged with GFP at the amino or carboxyl terminus., Limon A, Reyes-Ruiz JM, Eusebi F, Miledi R., Proc Natl Acad Sci U S A. September 25, 2007; 104 (39): 15526-30.


Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels., Cohen-Kashi Malina K, Ganor Y, Levite M, Teichberg VI., Neurochem Res. October 1, 2006; 31 (10): 1181-90.


3-hydroxypyridazine 1-oxides as carboxylate bioisosteres: a new series of subtype-selective AMPA receptor agonists., Greenwood JR, Mewett KN, Allan RD, Martín BO, Pickering DS., Neuropharmacology. July 1, 2006; 51 (1): 52-9.


Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2., Frandsen A, Pickering DS, Vestergaard B, Kasper C, Nielsen BB, Greenwood JR, Campiani G, Fattorusso C, Gajhede M, Schousboe A, Kastrup JS., Mol Pharmacol. March 1, 2005; 67 (3): 703-13.


Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis., Watson R, Jiang Y, Bermudez I, Houlihan L, Clover L, McKnight K, Cross JH, Hart IK, Roubertie A, Valmier J, Hart Y, Palace J, Beeson D, Vincent A, Lang B., Neurology. July 13, 2004; 63 (1): 43-50.


Ethanol sensitivity of recombinant homomeric and heteromeric AMPA receptor subunits expressed in Xenopus oocytes., Akinshola BE, Yasuda RP, Peoples RW, Taylor RE., Alcohol Clin Exp Res. December 1, 2003; 27 (12): 1876-83.


A role for extracellular Na+ in the channel gating of native and recombinant kainate receptors., Paternain AV, Cohen A, Stern-Bach Y, Lerma J., J Neurosci. September 24, 2003; 23 (25): 8641-8.


Glutamate receptor subunit 3 is modified by site-specific limited proteolysis including cleavage by gamma-secretase., Meyer EL, Strutz N, Gahring LC, Rogers SW., J Biol Chem. June 27, 2003; 278 (26): 23786-96.


Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO)., Bjerrum EJ, Kristensen AS, Pickering DS, Greenwood JR, Nielsen B, Liljefors T, Schousboe A, Bräuner-Osborne H, Madsen U., J Med Chem. May 22, 2003; 46 (11): 2246-9.


A desensitization-selective potentiator of AMPA-type glutamate receptors., Sekiguchi M, Nishikawa K, Aoki S, Wada K., Br J Pharmacol. August 1, 2002; 136 (7): 1033-41.


Straight-chain alcohols exhibit a cutoff in potency for the inhibition of recombinant glutamate receptor subunits., Akinshola BE., Br J Pharmacol. July 1, 2001; 133 (5): 651-8.


Identification of amino acid residues in GluR1 responsible for ligand binding and desensitization., Banke TG, Greenwood JR, Christensen JK, Liljefors T, Traynelis SF, Schousboe A, Pickering DS., J Neurosci. May 1, 2001; 21 (9): 3052-62.


Resolution, configurational assignment, and enantiopharmacology of 2-amino-3-[3-hydroxy-5-(2-methyl-2H- tetrazol-5-yl)isoxazol-4-yl]propionic acid, a potent GluR3- and GluR4-preferring AMPA receptor agonist., Vogensen SB, Jensen HS, Stensbøl TB, Frydenvang K, Bang-Andersen B, Johansen TN, Egebjerg J, Krogsgaard-Larsen P., Chirality. November 1, 2000; 12 (10): 705-13.


Electrophysiological characterization of CGP68730A a N-methyl-D-aspartate antagonist acting at the strychnine-insensitive glycine site., Pozza MF, Zimmerman K, Bischoff S, Lingenhöhl K., Prog Neuropsychopharmacol Biol Psychiatry. May 1, 2000; 24 (4): 647-70.


The contributions of GluR2 to allosteric modulation of AMPA receptors., Cotton JL, Partin KM., Neuropharmacology. January 1, 2000; 39 (1): 21-31.


A desensitization-inhibiting mutation in the glutamate binding site of rat alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor subunits is dominant in heteromultimeric complexes., Thalhammer A, Morth T, Strutz N, Hollmann M., Neurosci Lett. December 31, 1999; 277 (3): 161-4.


Lithium modulates desensitization of the glutamate receptor subtype gluR3 in Xenopus oocytes., Karkanias NB, Papke RL., Neurosci Lett. December 31, 1999; 277 (3): 153-6.


In-vitro and in-vivo action of cannabinoids., Akinshola BE, Chakrabarti A, Onaivi ES., Neurochem Res. October 1, 1999; 24 (10): 1233-40.


Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA., Stensbøl TB, Borre L, Johansen TN, Egebjerg J, Madsen U, Ebert B, Krogsgaard-Larsen P., Eur J Pharmacol. September 10, 1999; 380 (2-3): 153-62.


Anandamide inhibition of recombinant AMPA receptor subunits in Xenopus oocytes is increased by forskolin and 8-bromo-cyclic AMP., Akinshola BE, Taylor RE, Ogunseitan AB, Onaivi ES., Naunyn Schmiedebergs Arch Pharmacol. September 1, 1999; 360 (3): 242-8.


Arachidonic acid potentiates currents through Ca2+-permeable AMPA receptors by interacting with a CaMKII pathway., Nishizaki T, Matsuoka T, Nomura T, Enikolopov G, Sumikawa K., Brain Res Mol Brain Res. April 6, 1999; 67 (1): 184-9.


Subtype-specific effects of lithium on glutamate receptor function., Karkanias NB, Papke RL., J Neurophysiol. April 1, 1999; 81 (4): 1506-12.


Resolution, absolute stereochemistry, and enantiopharmacology of the GluR1-4 and GluR5 antagonist 2-amino-3-[5-tert-butyl-3-(phosphonomethoxy)-4-isoxazolyl]propionic acid., Møller EH, Egebjerg J, Brehm L, Stensbøl TB, Johansen TN, Madsen U, Krogsgaard-Larsen P., Chirality. January 1, 1999; 11 (10): 752-9.


Neurosteroid modulation of recombinant ionotropic glutamate receptors., Yaghoubi N, Malayev A, Russek SJ, Gibbs TT, Farb DH., Dev Biol. August 24, 1998; 803 (1-2): 153-60.


Molecular and electrophysiological characterizations of fGluR3 alpha, an ionotropic glutamate receptor subunit of a teleost fish., Chang HM, Wu YM, Chang YC, Hsu YC, Hsu HY, Chen YC, Chow WY., Brain Res Mol Brain Res. June 15, 1998; 57 (2): 211-20.


The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors., Donevan SD, Beg A, Gunther JM, Twyman RE., J Pharmacol Exp Ther. May 1, 1998; 285 (2): 539-45.


Pharmacological detection of AMPA receptor heterogeneity by use of two allosteric potentiators in rat hippocampal cultures., Sekiguchi M, Takeo J, Harada T, Morimoto T, Kudo Y, Yamashita S, Kohsaka S, Wada K., Br J Pharmacol. April 1, 1998; 123 (7): 1294-303.


Selective actions of a detergent on ligand-gated ion channels expressed in Xenopus oocytes., Machu TK, Mihic SJ, Dildy-Mayfield JE., J Pharmacol Exp Ther. January 1, 1998; 284 (1): 32-6.


Block of open channels of recombinant AMPA receptors and native AMPA/kainate receptors by adamantane derivatives., Magazanik LG, Buldakova SL, Samoilova MV, Gmiro VE, Mellor IR, Usherwood PN., J Physiol. December 15, 1997; 505 ( Pt 3) 655-63.


Comparison of the agonist binding site of homomeric, heteromeric, and chimeric GluR1(o) and GluR3(o) AMPA receptors., Banke TG, Schousboe A, Pickering DS., J Neurosci Res. July 15, 1997; 49 (2): 176-85.


Effects of external calcium on zinc modulation of AMPA receptors., Dreixler JC, Leonard JP., Dev Biol. March 28, 1997; 752 (1-2): 170-4.


Dominant negative mutant of ionotropic glutamate receptor subunit GluR3: implications for the role of a cysteine residue for its channel activity and pharmacological properties., Watase K, Sekiguchi M, Matsui TA, Tagawa Y, Wada K., Biochem J. March 1, 1997; 322 ( Pt 2) 385-91.


Pharmacological differentiation between neuronal and recombinant glutamate receptor channels expressed in Xenopus oocytes., Blaschke M, Gremmels D, Everts I, Weigand E, Heinemann SF, Hollmann M, Keller BU., Neuropharmacology. January 1, 1997; 36 (11-12): 1489-501.


Thiocyanate ions inhibit AMPA-activated currents in recombinant non-NMDA receptors expressed in Xenopus laevis oocytes: the role of the GluR2 subunit., Eugène D, Moss SJ, Smart TG., Eur J Neurosci. September 1, 1996; 8 (9): 1983-93.


Actions of long chain alcohols on GABAA and glutamate receptors: relation to in vivo effects., Dildy-Mayfield JE, Mihic SJ, Liu Y, Deitrich RA, Harris RA., Br J Pharmacol. May 1, 1996; 118 (2): 378-84.


Anesthetics produce subunit-selective actions on glutamate receptors., Dildy-Mayfield JE, Eger EI, Harris RA., J Pharmacol Exp Ther. March 1, 1996; 276 (3): 1058-65.


CDNA cloning of chick brain alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors reveals conservation of structure, function and post-transcriptional processes with mammalian receptors., Paperna T, Lamed Y, Teichberg VI., Brain Res Mol Brain Res. February 1, 1996; 36 (1): 101-13.


Ethanol inhibits kainate responses of glutamate receptors expressed in Xenopus oocytes: role of calcium and protein kinase C., Dildy-Mayfield JE, Harris RA., J Neurosci. April 1, 1995; 15 (4): 3162-71.


Topology profile for a glutamate receptor: three transmembrane domains and a channel-lining reentrant membrane loop., Bennett JA, Dingledine R., Neuron. February 1, 1995; 14 (2): 373-84.


Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins., Stern-Bach Y, Bettler B, Hartley M, Sheppard PO, O'Hara PJ, Heinemann SF., Neuron. December 1, 1994; 13 (6): 1345-57.


A deletion in the second cytoplasmic loop of GluR3 produces a dominant negative mutant of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor., Sekiguchi M, Doi K, Zhu WS, Watase K, Yokotani N, Wada K, Wenthold RJ., J Biol Chem. May 20, 1994; 269 (20): 14559-65.


Sensitivity of AMPA receptors to pentobarbital., Taverna FA, Cameron BR, Hampson DL, Wang LY, MacDonald JF., Eur J Pharmacol. May 17, 1994; 267 (3): R3-5.


Activation of protein kinase C inhibits kainate-induced currents in oocytes expressing glutamate receptor subunits., Dildy-Mayfield JE, Harris RA., J Neurochem. April 1, 1994; 62 (4): 1639-42.


Subunit-specific enhancement of glutamate receptor responses by zinc., Dreixler JC, Leonard JP., Brain Res Mol Brain Res. March 1, 1994; 22 (1-4): 144-50.


A single amino acid determines the subunit-specific spider toxin block of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor channels., Blaschke M, Keller BU, Rivosecchi R, Hollmann M, Heinemann S, Konnerth A., Proc Natl Acad Sci U S A. July 15, 1993; 90 (14): 6528-32.


Neurotransmitter receptors and voltage-dependent Ca2+ channels encoded by mRNA from the adult corpus callosum., Matute C, Miledi R., Proc Natl Acad Sci U S A. April 15, 1993; 90 (8): 3270-4.


Identification of a subunit-specific antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate/kainate receptor channels., Keller BU, Blaschke M, Rivosecchi R, Hollmann M, Heinemann SF, Konnerth A., Proc Natl Acad Sci U S A. January 15, 1993; 90 (2): 605-9.

???pagination.result.page??? 1 2 ???pagination.result.next???